Highest-paid CEOs in 2018: Who made the list from healthcare

By Emily Rappleye for Becker’s Hospital Review

Thirty-two healthcare CEOs made The New York Times and Equilar’s 2018 ranking of highest-paid CEOs in 2018.

Of those 32, three executives led some of the nation’s largest for-profit hospital systems: King of Prussia, Pa.-based Universal Health Services, Nashville, Tenn.-based HCA Healthcare and Dallas-based Tenet Healthcare. The full list includes 200 chief executives from public companies with revenue of at least $1 billion.

Here are the 32 healthcare companies and CEOs that made the list, in order of total compensation in 2018. Total compensation may include salary, bonuses, perks, stock and options.

1. Hologic, Stephen MacMillan — $42 million
2. Align Technology, Joseph Hogan — $42 million
3. Regeneron Pharmaceuticals, Leonard Schleifer — $27 million
4. Centene, Michael Neidorff — $26 million
5. Universal Health Services, Alan Miller — $24 million
6. Abbott Laboratories, Miles White — $23 million
7. CVS Health, Larry Merlo — $22 million
8. Merck, Kenneth Frazier — $21 million
9. Abbvie, Richard Gonzalez — $21 million
10. Johnson & Johnson, Alex Gorsky — $20 million
11. HCA Healthcare, R. Milton Johnson — $20 million
12. Pfizer, Ian Read — $20 million
13. Bristol-Myers Squibb, Giovanni Caforio — $19 million
14. Cigna, David Cordani — $19 million
15. Vertex Pharmaceuticals, Jeffrey Leiden — $19 million
16. Thermo Fisher Scientific, Marc Casper — $19 million
17. Amgen, Robert Bradway — $19 million
18. UnitedHealth Group, David Wichmann — $18 million
19. DaVita, Kent Thiry — $17 million
20. Gilead Sciences, John Milligan — $17 million
21. Alexion Pharmaceuticals, Ludwig Hantson — $16 million
22. Humana, Bruce Broussard — $16 million
23. Celgene, Mark Alles — $16 million
24. Biogen, Michel Vounatsos — $16 million
25. United Therapeutics, Martine Rothblatt — $16 million
26. IQVIA Holdings, Ari Bousbib — $16 million
27. Eli Lilly, David Ricks — $16 million
28. Baxter International, José Almeida — $16 million
29. Biomarin Pharmaceutical, Jean-Jacques Bienaimé — $16 million
30. Danaher, Thomas Joyce Jr. — $15 million
31. Molina Healthcare, Joseph Zubretsky — $15 million
32. Tenet Healthcare, Ron Rittenmeyer — $15 million